News Release

Mallinckrodt to Present at Leerink Swann Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--Feb. 5, 2014-- Mallinckrodt plc (NYSE: MNK), a global specialty pharmaceutical and global medical imaging company, will present at the Leerink Swann Global Healthcare Conference in New York on February 13, 2014. The senior management of Mallinckrodt will participate in a fireside chat scheduled to begin at 10:45AM EST.

A live audio webcast of the presentation can be accessed at Mallinckrodt’s Investor Relations website: A replay will be available on the website following the conclusion of the meeting.


Mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s Specialty Pharmaceuticals segment includes branded and generic drugs and active pharmaceutical ingredients, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in roughly 70 countries. The company’s fiscal 2013 revenue totaled $2.2 billion. To learn more about Mallinckrodt, visit

Source: Mallinckrodt

John Moten, 314-654-6650
Vice President, Investor Relations
Lynn Phillips, 314-654-3263
Manager, Media Relations